Abstract:Abstract: Objective To explore the feasibility, safety and cost-effectiveness of painless bronchoscopic technique in different groups which under different anesthesia, sedation and analgesic drugs. Methods 150 patients underwent bronchoscopy were randomly divided into the groups A, B, C, D and E. Group A: was given mucosal surface anesthesia with Lidocaine; Group B: was given mucosal surface anesthesia with Lidocaine and intravenous anesthesia with Dexmedetomidine (DEX) and Fentanyl; Group C: was given mucosal surface anesthesia with Lidocaine and intravenous anesthesia with Midazolam and Fentanyl; Group D: was given mucosal surface anesthesia with Lidocaine and intravenous anesthesia with Propofol and Fentanyl; Group E: was given mucosal surface anesthesia with Lidocaine and intravenous anesthesia with Midazolam and Propofol. During bronchoscopic operations, the feasibility, safety and cost-effectiveness of different groups were judged and compared by anesthetic effect, the reactivity of bronchoscopy, the completion of operations and the subjective feelings of patients. Results Drug regimens of Group B and D were better than other groups in the following aspects: anesthetic effects, the reactivity of bronchoscopic operations, the completion of operations and the subjective feelings of patients.Furthermore, Group B was better than Group D. Conclusions When patients who underwent painless bronchoscopy, it is more reasonable, safe and effective to provide the corresponding painless drug regimens for different patients and conditions. Which is more acceptable to patients.